Abstract
Despite a totality of evidence indicating clear benefits of statin therapy in secondary and primary prevention of cardiovascular disease (CVD), a large number of additional trials are currently planned or in progress to help us better understand, treat, and prevent CVD. Both monotherapy and combination statin regimens are being studied to optimize treatment of the total patient and to assess mechanisms and benefits of various components of the total lipid profile.
Keywords: totality of evidence, statin, cardiovascular disease, dyslipidemias
Full Text
The Full Text of this article is available as a PDF (78.4 KB).